(RVNC/Evolus)—Botulinum toxin from Korea might be a scary thought. However, for the sake of discussion, let’s assume that Evolus manages to obtain FDA approval of DWP-415’s Korean manufacturing facilities as well as the other modules of the pending BLA. Even then, I wonder if the marketing of DWP-415 would be impaired to some degree on account of where the stuff comes from.
Market Data 
Markets 
AI
